beta

AKCA

Akcea Therapeutics Inc.

Akca

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.

Market Cap: 1.29 Billion

Primary Exchange: Nasdaq Global Select

Website: http://www.akceatx.com

Shares Outstanding: 66.5 Million

Float: 66.5 Million

Dividend: 0.0 (0.0%)

Beta: -0.614617

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 3.82 Million

Ethical Flags

Animal testing

Longest drawdown: 304 trading days

From: 2018-08-07 To: 2019-10-18

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud